Skull bone injection vs. IV for large stroke
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests a new way to give medicine for a large stroke on one side of the brain. The medicine is injected into the skull bone instead of through a vein, and researchers want to see if it works better and is safe.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 80 years old
- This is your first stroke or you could take care of yourself before it
- You can get treatment within 24 hours of your stroke starting
- Your stroke is large and affects one side of the brain (middle cerebral artery area)
- Your stroke symptoms are moderate to severe (NIHSS score 16-32) and not improving after other treatments
- You do not have other serious brain conditions, bleeding problems, or severe organ disease
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way to deliver a medication called RK-4 directly into the skull bone marrow to bypass the blood-brain barrier for people with a major stroke on one side of the brain. The goal is to see if this injection is safe and feasible, and it might help reduce damage after a severe stroke.
This trial tests whether a clot-busting drug given directly into the brain artery can improve recovery after a major stroke caused by a blockage in the front part of the brain. The study is for people whose blood flow has already been successfully restored with standard treatments.
This trial tests an investigational drug, QHRD106, given as an injection for people who have had a moderate-to-severe acute ischemic stroke. It aims to see if the drug can help recovery when given within 24 hours after the stroke starts, and it is for patients who are not receiving standard clot-busting treatment.
This trial tests whether injecting a special solution (RK-4) into the skull can help people with a severe type of stroke caused by a blockage in a major brain artery. The treatment aims to reduce brain damage and improve recovery when given within 24 hours of the stroke.
This trial tests an experimental treatment called RK-4 that is given directly into the bone of the skull shortly after a severe stroke. The goal is to see if it can improve recovery and reduce disability from a major stroke on one side of the brain.
This trial tests if a procedure to remove a large blood clot from the brain (called a thrombectomy) can help people with severe strokes who have a large damaged area. It is for people who can be treated within 24 hours of their stroke starting.
Hear when a new Blood-Brain Barrier trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.